Related Experiment Video
Updated: Jun 25, 2026
10:16
Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
Published on: February 8, 2017
Copolymeric nanofilm platform for controlled and localized therapeutic delivery
Edward Kai-Hua Chow1, Erik Pierstorff, Genhong Cheng
1Molecular Biology Institute, University of California Los Angeles, Los Angeles, California 90095, USA.
ACS Nano
|February 12, 2009
Summary
This study developed a novel nanomaterial (PolyDex) by combining a block copolymer with dexamethasone for targeted anti-inflammatory drug delivery. PolyDex effectively reduced inflammation both in vitro and in vivo, showcasing its potential for advanced therapeutic applications.
Area of Science:
- Biomaterials Science
- Nanomedicine
- Drug Delivery Systems
Background:
- Block copolymeric membranes offer biomimetic properties for integrating therapeutic materials.
- Nanomaterials are engineered for specific applications like controlled and localized drug delivery.
- Polymethyl oxazoline-polydimethylsiloxane-polymethyl oxazoline (PMOXA-PDMS-PMOXA) is a versatile synthetic nanomembrane matrix.
Purpose of the Study:
- To functionalize PMOXA-PDMS-PMOXA block copolymers with anti-inflammatory molecules.
- To develop a copolymer-therapeutic hybrid for an anti-inflammatory drug delivery system.
- To create dexamethasone-copolymer mixtures (PolyDex) for localized anti-inflammatory therapy.
Main Methods:
- Utilized self-assembly and Langmuir-Blodgett deposition to mix copolymers with dexamethasone (Dex).
- Confirmed copolymer-drug mixing using surface pressure isotherms and fluorescence microscopy.
- Evaluated PolyDex's anti-inflammatory effects in vitro and in vivo through cytokine expression analysis and tissue biopsies.
Main Results:
- PolyDex, at 4 nm thickness per layer, suppressed in vitro expression of inflammatory cytokines (IL-6, IL-12, TNF-alpha, iNOS, IP-10).
- In vivo studies using punch biopsies confirmed PolyDex's sustained anti-inflammatory properties.
- Hematoxylin/eosin and CD11b staining validated the in vivo efficacy.
Conclusions:
- PolyDex serves as a localized, efficient drug-copolymer composite for active therapeutic delivery.
- The developed material can confer anti-inflammatory protection.
- PolyDex acts as a platform material for broad drug elution capabilities.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:22Drug Delivery: Miscellaneous Routes
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...